Results 1 to 10 of about 30,013 (229)

Gemfibrozil-Induced Polyuria [PDF]

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2021
Gemfibrozil is a lipid-regulating agent used mainly to treat patients with hypertriglyceridaemia, especially those at risk for acute pancreatitis. Like any other pharmacological agent, gemfibrozil has known adverse effects, mainly gastrointestinal, such ...
Ashraf Ahmed   +2 more
doaj   +2 more sources

The Relations between Enuresis in Childhood and Nocturnal Polyuria Syndrome in Adult Life [PDF]

open access: yesInternational Neurourology Journal, 2012
Purpose The aim of this study, to investigate whether there is any association between enuresis in childhood and nocturnal polyuria syndrome (NPS) in adult life. Methods The study consisted of thirty five patients with nocturnal polyuria, and thirty five
Halil Ciftci   +5 more
doaj   +2 more sources

Tachycardia-polyuria syndrome after swan-ganz catheterization in liver transplant patient - A case report - [PDF]

open access: yesAnesthesia and Pain Medicine, 2021
Background Tachycardia-polyuria syndrome is characterized by polyuria occurring because of tachycardia with a heart rate of ≥ 120 beats/min lasting ≥ 30 min. We report such a case occurring after swan-ganz catheterization.
Sang-Kwon Heo   +3 more
doaj   +2 more sources

Decreased nitric oxide production is a novel therapeutic target for salt-induced nocturnal polyuria in aging

open access: yesScientific Reports
Nocturnal polyuria is a major cause of nocturia, which affects quality of life. Aging-related decreases in nitric oxide production have been reported to contribute to salt-induced nocturnal polyuria.
Takahiro Imanaka   +11 more
doaj   +2 more sources

Dexmedetomidine-associated polyuria mimicking diabetes insipidus [PDF]

open access: yesEuropean Journal of Case Reports in Internal Medicine
Dexmedetomidine is a highly selective alpha-2-adrenergic agonist widely used for sedation in the intensive care unit (ICU) and is generally considered well tolerated, with hypotension and bradycardia being the most commonly reported adverse effects ...
Sankalp Acharya   +6 more
doaj   +2 more sources

PROLONGED MASSIVE POLYURIA AFTER RENAL TRANSPLANTATION

open access: yesВестник трансплантологии и искусственных органов, 2012
Clinical case of prolonged massive polyuria in patient after renal transplantation is represented in this article. Polyuria lasted for a forty days after kidney transplantation, the larges amount of urine output was 55 litres per day.
A. M. Chernyavskiy   +4 more
doaj   +3 more sources

Nocturnal Polyuria: Excess of Nocturnal Urine Production, Excess of Definitions—Influence on Renal Function Profile

open access: yesJournal of Urology, 2016
Purpose: This study aimed to identify important differences in renal function profile, and potential water and sodium diuresis cutoffs among participants with nocturnal polyuria according to nocturnal polyuria definitions.
Johan Vande Walle   +2 more
exaly   +2 more sources

The Association between Nocturia and Nocturnal Polyuria in Clinical and Epidemiological Studies: A Systematic Review and Meta-Analyses

open access: yesJournal of Urology, 2014
Purpose: We determined the relationship between nocturia and nocturnal polyuria. Materials and Methods: The PubMed (R) and Embase (R) databases were searched for studies written in English, German, French or Dutch with original data on adult participants
Boudewijn J Kollen   +2 more
exaly   +2 more sources

‘Frequently recurring’ nocturnal polyuria is predictive of response to desmopressin in monosymptomatic nocturnal enuresis in childhood

open access: yesJournal of Pediatric Urology, 2019
Introduction: The nocturnal polyuria is considered a significant predictive value for response to desmopressin. The cutoff value useful to define nocturnal polyuria is still a matter of debate.
Pierluigi Marzuillo   +2 more
exaly   +2 more sources

Xanomeline/trospium-induced polyuria: A patient case report [PDF]

open access: yesMental Health Clinician
Xanomeline/trospium is a newly approved agent for the management of schizophrenia. Unlike traditional antipsychotics, which are D2 receptor antagonists, xanomeline is an M1/M4 muscarinic acetylcholine receptor agonist coformulated with trospium, a ...
Henry Leach, PharmD, BCPP   +1 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy